284 Stratification of mortality by risk scores from the EPHESUS trial reveals significant interaction between left ventricular ejection fraction and Killip class
B. Pitt,
B. Pitt
University of Michigan Medical Center, Ann Arbor, Mi, United States of America
Search for more papers by this author F. Zannad,
F. Zannad
Inserm, Centre d Investigations Cliniques CI, Nancy, France
Search for more papers by this author D.J. Van Veldhuisen,
D.J. Van Veldhuisen
University Medical Center Groningen, Groningen, Netherlands
Search for more papers by this author S. Sutradhar,
S. Sutradhar
Pfizer Inc, New York, Ny, United States of America
Search for more papers by this author J. Vincent,
J. Vincent
Pfizer Inc, New York, Ny, United States of America
Search for more papers by this author
B. Pitt,
B. Pitt
University of Michigan Medical Center, Ann Arbor, Mi, United States of America
Search for more papers by this author F. Zannad,
F. Zannad
Inserm, Centre d Investigations Cliniques CI, Nancy, France
Search for more papers by this author D.J. Van Veldhuisen,
D.J. Van Veldhuisen
University Medical Center Groningen, Groningen, Netherlands
Search for more papers by this author S. Sutradhar,
S. Sutradhar
Pfizer Inc, New York, Ny, United States of America
Search for more papers by this author J. Vincent,
J. Vincent
Pfizer Inc, New York, Ny, United States of America
Search for more papers by this author
First published: 23 June 2008
No abstract is available for this article.
